By Ashley Milano  |  November 9, 2015

Category: Legal News

Risperdal side effectsResearch dating back to before 1994 indicates that Johnson & Johnson’s drug Risperdal had dangerous side effects, especially harmful emotional and physical side effects in adolescent boys.

Some of these common Risperdal side effects include significant weight gain and male breast growth, also known as gynecomastia.

What is Gynecomastia?

Gynecomastia is enlargement or development of breast tissue in males.  It is more common and particularly disturbing in children and adolescents.  The development of Risperdal gynecomastia is usually a permanent change that will require surgical removal by a reconstructive surgeon.

Male breast growth has been attributed to Risperdal’s stimulation of prolactin, a hormone common in women who are pregnant or nursing.  Adolescents or boys who develop breast tissue suffer not only physical changes but also severe emotional trauma.

This psychological trauma and expenses related to gynecomastia surgery have led to dozens of lawsuits against Johnson & Johnson by plaintiffs seeking compensation for damages related to Risperdal side effects.

Risperdal Label Minimizes Gynecomastia Side Effect

Several issues surround the marketing and the prescribing of this drug. Johnson & Johnson, the manufacturers and marketers of Risperdal, allegedly used language on the label that minimized and downplayed the harmful side effects of this medication.

In addition to this, they also claimed that their drug was safer and more superior than other antipsychotic medications in its class even though sufficient evidence did not exist to validate that claim.

With the help of these claims and the company’s aggressive marketing schemes, physicians readily prescribed this medication for off-label uses.

A 2008 Wall Street Journal article cautioned that a Risperdal male breast growth warning is most important for adolescents taking the drug.

The blog article reported as far back as November 2008 on how “Risperdal Can Have Troubling Side Effects in Boys”, and how litigation was pending because of the link between using Risperdal and male breast growth.

Risperdal Gynecomastia Risks

Risperidone, manufactured by Johnson & Johnson and sold as Risperdal, is an antipsychotic drug that was first approved by the U.S. Food and Drug Administration (FDA) in 1993, and is used as a treatment for schizophrenia, mania, and irritability associated with autistic disorder in children and teenagers.

Risperdal belongs to a class of drugs known as atypical antipsychotics, and works by altering certain substances in the brain.

To date, 27 different studies have been conducted since 1998 that demonstrate the link of Risperdal use to gynecomastia.  In 2006, one such study published in the Journal of Clinical Psychopharmacology found that the use of risperidone in children was associated with excessive levels of the hormone prolactin, which is tied to female breast development and lactation.

Three years later, research published in the Journal of Child and Adolescent Psychopharmacology revealed that these high levels of prolactin could persist for as many as two years, stating that “Current users of risperidone (which is the generic name for Risperdal) had approximately four times the risk of developing gynecomastia than non-users. When the analysis was stratified to children and adolescents (≤18 years of age) taking risperidone, the risk of gynecomastia was five times higher than for non-users.”

Risperdal Lawsuits

Risperdal lawsuits are mounting in courts around the country on behalf of men and boys who allegedly developed gynecomastia, or male breast growth, due to their use of the antipsychotic drug.

In fact, as of October 2012, Johnson & Johnson had already settled a handful of Risperdal lawsuits, even as the litigation surrounding the medication continued to grow.

Just this past year, one of these Risperdal Gynecomastia lawsuits resulted in a judgement award of $2.5 million for the plaintiff.

If you or a loved one developed gynecomastia or other harmful side effects as a result of taking Risperdal, you may be entitled to compensation for your pain and suffering.

Do YOU have a legal claim? Fill out the form on this page now for a free, immediate, and confidential case evaluation. The Risperdal attorneys who work with Top Class Actions will contact you if you qualify to let you know if an individual lawsuit or Risperdal class action lawsuit is best for you. [In general, Risperdal lawsuits are filed individually by each plaintiff and are not class actions.] Hurry — statutes of limitations may apply.

Learn More

We tell you about cash you can claim EVERY WEEK! Sign up for our free newsletter.


Get Help – It’s Free

Join a Free Risperdal Class Action Lawsuit Investigation

If you or your son took Risperdal between the ages of 10 and 18 years old and suffered gynecomastia (male breast growth), male breast pain, nipple pain, or nipple discharge, you may be entitled to compensation. See if you qualify by submitting your information below for a free and confidential case review.

An attorney will contact you if you qualify to discuss the details of your potential case at no charge to you.

Oops! We could not locate your form.

Leave a Reply

Your email address will not be published. By submitting your comment and contact information, you agree to receive marketing emails from Top Class Actions regarding this and/or similar lawsuits or settlements, and/or to be contacted by an attorney or law firm to discuss the details of your potential case at no charge to you if you qualify. Required fields are marked *

Please note: Top Class Actions is not a settlement administrator or law firm. Top Class Actions is a legal news source that reports on class action lawsuits, class action settlements, drug injury lawsuits and product liability lawsuits. Top Class Actions does not process claims and we cannot advise you on the status of any class action settlement claim. You must contact the settlement administrator or your attorney for any updates regarding your claim status, claim form or questions about when payments are expected to be mailed out.